Table 1.
Some amyloidoses and their respective precursors and amyloid-ogenic proteins
| Disease | Precursor protein | Amyloid protein |
| Alzheimer's disease | Amyloid precursor protein | Aβ peptides |
| Atrial amyloidosis | Atrial natriuretic factor (ANF) | Amyloid ANF |
| Spongiform encephalopathies | Prion protein (PrPc) | PrPsc |
| Primary systemic amyloidosis | Immunoglobulin light and heavy chains | AL and AH |
| Senile systemic amyloidosis | Wild-type transthyretin | ATTR |
| Haemodialysis-related amyloidosis | β2-microglobulin | Aβ2M |
| Hereditary nonneuropathic systemic amyloidosis | Lysozyme | ALys |
| Type II diabetes | Pro-IAPP | IAPP or “amylin” |
| Injection-localized amyloidosis | Insulin | AIns |
| Secondary systemic amyloidosis | (Apo) serum amyloid A | Serum amyloid A |
| Hereditary cerebral amyloid angiopathy | Cystatin C | ACys |
| Finnish hereditary systemic amyloidosis | Gelsolin | AGel |
| Familial amyloid polyneuropathy I | Transthyretin variants | ATTR |
| Familial amyloid polyneuropathy II | Apolipoprotein A1 | AApoA1 |
| Ageing pituitary, prolactinomas | Prolactin | APro |
| Familial amyloidosis | Fibrinogen αA-chain | AFib |
| British familial dementia | Amyloid Bri Precursor Protein | ABri |